Siritantikorn S, Laiwejpithaya S, Siripanyaphinyo U, Auewarakul P, Yenchitsomanus P, Thakernpol K, Wasi C
Department of Microbiology, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand.
Southeast Asian J Trop Med Public Health. 1997 Dec;28(4):707-10.
We detected and typed HPV-DNA by polymerase chain reaction (PCR) in cervico-vaginal lavages of 102 women with normal cervical cytology, 57 patients with cervical intraepithelial neoplasia (CIN), and 23 cervical cancer patients. HPV-DNA detection and typing by in situ hybridization were also performed in cervical biopsies from CIN lesions and cancers. Five percent of women with normal cervical cytology, 46% of CIN, and 61% of cervical cancer were positive for HPV-DNA. Of CIN cases with positive HPV-DNA, 69, 15, 8, 4 and 4% were HPV-16, -33, -18, -11 and -16/33 respectively. Of cervical cancer cases with positive HPV-DNA, 86% were HPV-16, 7% were HPV-16/33, 7% were HPV-18/31. HPV typing was performed in biopsies from 37 CIN and 18 cervical cancers by in situ hybridization. By this method, 38% of CIN were HPV-DNA positive, of which 71% were HPV-16 and 7% were each of HPV-11, -18, -31 and -33. Thirty-nine percent of cervical cancers were positive, of which 71% and 29% were HPV-16 and HPV-16/18 respectively.
我们采用聚合酶链反应(PCR)对102例宫颈细胞学正常的女性、57例宫颈上皮内瘤变(CIN)患者及23例宫颈癌患者的宫颈阴道灌洗液进行HPV-DNA检测及分型。同时,对CIN病变及癌组织的宫颈活检标本进行原位杂交HPV-DNA检测及分型。宫颈细胞学正常的女性中5%、CIN患者中46%、宫颈癌患者中61%的HPV-DNA呈阳性。HPV-DNA阳性的CIN病例中,HPV-16、-33、-18、-11及-16/33分别占69%、15%、8%、4%及4%。HPV-DNA阳性的宫颈癌病例中,HPV-16占86%,HPV-16/33占7%,HPV-18/31占7%。通过原位杂交对37例CIN及18例宫颈癌的活检标本进行HPV分型。采用该方法,38%的CIN为HPV-DNA阳性,其中71%为HPV-16,HPV-11、-18、-31及-33各占7%。39%的宫颈癌呈阳性,其中HPV-16及HPV-16/18分别占71%及29%。